Fast diabetes tests at your Doctor's office could save kidneys

NCT ID NCT06684990

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether using a fast point-of-care device to measure blood sugar control (HbA1c) and kidney function (cystatin C) during a clinic visit can improve long-term health in people with diabetes. Researchers will track changes in kidney function over time in 222 adults. The goal is to see if immediate results help doctors make better treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

point-of-care testing for HbA1c and cystatin C

What this could lead to

If successful, this could show that fast, in-clinic testing helps doctors manage diabetes better and slow kidney decline.

What could go wrong

This is an observational study without a control group, so results may not prove cause and effect. The benefit depends on how doctors use the test results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taichung Veterans General Hospital

    Taichung, 407219, Taiwan